The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTpximpact Hldg Regulatory News (TPX)

Share Price Information for Tpximpact Hldg (TPX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.00
Bid: 31.00
Ask: 33.00
Change: -0.50 (-1.54%)
Spread: 2.00 (6.452%)
Open: 32.50
High: 32.50
Low: 32.00
Prev. Close: 32.50
TPX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Current Trading and Notice of AGM

5 Sep 2023 13:05

RNS Number : 4548L
TPXimpact Holdings PLC
05 September 2023
 

5 September 2023

TPXimpact Holdings PLC

("TPXimpact", "TPX", the "Group" or the "Company")

Update on current trading and Notice of AGM

TPXimpact Holdings PLC, the technology-enabled services company focused on people-powered transformation, provides an update on current trading and notice of AGM.

Current trading

The Board is pleased to confirm trading in the three months to 30 June 2023 ("Q1 2024") was in line with management expectations, with like-for-like revenue growth of over 11% and operating margin in line with budget. As stated in the preliminary results new business wins exceeded £90 million in the quarter. Q2 2024 has started well, with like-for-like revenue growth of 26% in the month of July.

Net debt (excluding lease liabilities) was £17.9 million at 30 June 2023. The Group's new banking covenants came into effect on 1 July 2023 and liquidity has comfortably exceeded the relevant thresholds since that date.

Management remains committed to achieving the FY24 targets of like-for-like revenue growth of 15-20% and Adjusted EBITDA margin of 5-6% and are encouraged by the strong start to the year.

 

Notice of AGM

The Company has today posted its report and accounts for the financial year ended 31 March 2023, together with the notice of AGM, to those shareholders who have requested hard copies. Electronic copies of both documents are available to download on the Company's website at www.tpximpact.com/investor-relations in accordance with AIM Rule 20.

The Group's Annual General Meeting ("AGM") will be held on 28 September 2023 at 9:30 a.m. at the offices of Stifel Nicolaus Europe Limited, 150 Cheapside, Fourth Floor, London, EC2V 6ET.

TPX invites shareholders to submit questions in advance of the AGM by emailing them to tpx@almapr.co.uk.Questions should be submitted by 9 a.m. on 26 September 2023 and the Company will ensure, to the extent it is able to do so, that the answers are directly responded to, with responses to questions of common interest also made available on its website at www.tpximpact.com as soon as practical following the meeting.

 

ENDS 

 

Enquiries:

TPXimpact Holdings

Bjorn Conway, CEO

Steve Winters, CFO

Stifel Nicolaus Europe Limited

(Nomad and Joint Broker)

Fred Walsh

Ben Burnett

 

Via Alma PR

 

 

+44 (0) 207 710 7600

 

Dowgate Capital Limited

(Joint Broker)

James Serjeant

David Poutney

 

 

+44 (0) 203 903 7715

Alma PR

(Financial PR)

Josh Royston

Kieran Breheny

Matthew Young

tpx@almapr.co.uk

+44 (0) 203 405 0209

 

 

 About TPXimpact

We believe in a world enriched by people-powered digital transformation. Working together in close collaboration, we want to help our clients reimagine their organisations, services and experiences to accelerate positive change and build a future where people, places and the planet are supported to thrive.

Led by passionate people, we care deeply about the work we do and the impact we have in the world. Working alongside our clients teams, we work to understand their unique challenges and find new ways forward together; challenging assumptions, testing new approaches and building capabilities, leaving them with the tools, the insight and the confidence to continue iterating and innovating.

Combining rich heritage and expertise in human-centred design, data, experience and technology, we bring over 15 years experience across the public, private and third sectors, creating sustainable solutions with the flexibility to learn, evolve and change.

The business is being increasingly recognised as a leading alternative digital transformation provider to the UK public services sector, with c.72% of its client base representing the public sector and c.28% representing the commercial sector.

More information is available at www.tpximpact.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCNKPBKBBKDQCK
Date   Source Headline
10th Apr 202412:25 pmRNSReplacement: Share Incentive Plan & TVR
10th Apr 20247:00 amRNSShare Incentive Plan & Total Voting Rights
8th Apr 20247:00 amRNSExercise of Options, PDMR Dealings & TVR
3rd Apr 20247:00 amRNSPDMR / PCA Shareholdings
13th Mar 20247:00 amRNSShare Incentive Plan & Total Voting Rights
7th Mar 20243:15 pmRNSHolding(s) in Company
13th Feb 20247:00 amRNSDirector Dealings, Transfer of EBT Shares & TVR
16th Jan 20247:00 amRNSHolding(s) in Company
15th Jan 20247:00 amRNSDirector/PDMR Shareholdings
10th Jan 20247:00 amRNSTransfer of shares from EBT & Total Voting Rights
9th Jan 202410:30 amRNSTPXimpact Certifies as a B Corporation
12th Dec 20237:00 amRNSTransfer of Shares from EBT & Total Voting Rights
8th Dec 20237:00 amRNSExercise of Options, PDMR Dealings & TVR
5th Dec 20237:00 amRNSInterim Results
10th Nov 20231:34 pmRNSTransfer of shares from EBT & Total Voting Rights
7th Nov 20237:00 amRNSNotice of Results and Presentations
16th Oct 20237:00 amRNSH1 Trading Update & Disposal of TPXimpact Norway
12th Oct 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
28th Sep 202311:00 amRNSResult of AGM
22nd Sep 20237:00 amRNSPDMR Dealings: Grant of share options to Group CEO
18th Sep 20237:00 amRNSSale of Questers for £7.5m
14th Sep 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
5th Sep 20231:05 pmRNSUpdate on Current Trading and Notice of AGM
25th Aug 20231:03 pmRNSHolding(s) in Company
11th Aug 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
20th Jul 20237:00 amRNSTransfer of Shares from EBT & Total Voting Rights
19th Jul 20233:15 pmRNSHolding(s) in Company
6th Jul 20237:00 amRNSPreliminary Results
30th Jun 20237:00 amRNSAgreement on Debt Covenants and Notice of Results
14th Jun 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
6th Jun 20237:00 amRNSIssue of Shares & Total Voting Rights
11th May 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
5th May 20237:00 amRNSTrading Statement
28th Apr 20232:35 pmRNSTotal Voting Rights
28th Apr 202310:18 amRNSContract wins
14th Apr 20235:27 pmRNSHolding(s) in Company Update
13th Apr 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
3rd Apr 20233:30 pmRNSTotal Voting Rights
31st Mar 20237:00 amRNSCovenant Waiver and Current Trading
9th Mar 20237:00 amRNSTransfer of Shares from EBT & Total Voting Rights
1st Mar 20237:00 amRNSTotal Voting Rights
24th Feb 20237:00 amRNSIssue of Shares
16th Feb 20237:00 amRNSLTIP, PDMR Dealings & Retention Award
10th Feb 20234:31 pmRNSTransfer of shares from EBT & Total Voting Rights
9th Feb 20237:00 amRNSHolding(s) in Company
8th Feb 202312:06 pmRNSHolding(s) in Company
3rd Feb 20231:54 pmRNSDirector/PDMR Shareholding
2nd Feb 20232:45 pmRNSHolding(s) in Company
2nd Feb 20232:40 pmRNSHolding(s) in Company
2nd Feb 20237:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.